A Study of the Efficacy and Safety of Imatinib Mesylate in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing C-kit Gene
Clinical trial NCT00237185 · COMPLETED
Trial details
- NCT number
- NCT00237185
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2000-06-01
- Primary completion
- 2013-06-01
- Enrollment
- 148
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.